Mortality and economic cost in common primary cancer admitted with COVID-19: Analysis of NIS 2020.

Authors

null

Thanathip Suenghataiphorn

Griffin Hospital, Derby, CT

Thanathip Suenghataiphorn , Phuuwadith Wattanachayakul , Thitiphan Srikulmontri , Narathorn Kulthamrongsri , Nutchapon Xanthavanij , Narisara Tribuddharat , Kochakorn Buasri , Pojsakorn Danpanichkul , Sakditad Saowapa , Tuntanut Lohawatcharagul , Soravis Alm Osataphan

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Breakthrough

Session Type

Poster Session

Session Title

Poster Session A

Track

Gastrointestinal Cancer,Central Nervous System Tumors,Developmental Therapeutics,Genitourinary Cancer,Quality of Care,Healthcare Equity and Access to Care,Population Health,Viral-Mediated Malignancies

Sub Track

Real World Evidence/Real World Data

Citation

J Clin Oncol 42, 2024 (suppl 23; abstr 182)

DOI

10.1200/JCO.2024.42.23_suppl.182

Abstract #

182

Poster Bd #

J10

Abstract Disclosures

Similar Posters

First Author: Vaishali Deenadayalan

First Author: Hamid Ehsan

First Author: Dimpy P Shah

Poster

2022 ASCO Genitourinary Cancers Symposium

Effect of androgen receptor directed therapy in prostate cancer patients with COVID-19.

Effect of androgen receptor directed therapy in prostate cancer patients with COVID-19.

First Author: Serhan Unlu